All Updates

All Updates

icon
Filter
Industry news
Omeat constructs pilot plant for cultivated meat
Cell-cultured Meat
Nov 8, 2023
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Cell-cultured Meat

Cell-cultured Meat

Nov 8, 2023

Omeat constructs pilot plant for cultivated meat

Industry news

  • Omeat, a cultivated meat startup, has completed the construction of a pilot facility with a capacity to produce 400 tons of product annually.

  • Situated outside Los Angeles, the 15,000 sq ft pilot facility houses bioreactors of up to 10,000 liters capacity. The company expects this plant to provide insights for scaling production and observing quality, taste, and safety standards.

  • Analyst QuickTake: Omeat is on a rapid growth trajectory, having only emerged from stealth a few months ago. The construction of this facility follows the development of its B2B arm for selling its ethical fetal bovine serum alternative, putting the company on track to becoming one of the quickest cell-cultured companies to begin revenue generation.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.